Marie‐Hélène Delfau‐Larue

Author

Also Known As

Au-Yeung, Rex K.H., Bouabdallah, Reda, Delfau-Larue, Delfau-Larue, Marie, Delfau-Larue, Marie-Helene, Delfau-Larue, Marie-Hélène, M Delfau-Larue, M Delfau‐Larue, M H Delfau-Larue, M H Delfau‐Larue

250

Publications

Citations

H-Index

Concepts

All Affiliations

Inserm Assistance Publique – Hôpitaux de Paris Université Paris-Est Créteil Université Paris Cité Centre Hospitalier Universitaire Henri-Mondor

About

Marie‐Hélène Delfau‐Larue is an author at Inserm specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	45	3.1K
2	Health Sciences	5	5	141
3	Natural Sciences	2	2	116
4	Allergy	1	1	58
5	Biochemistry	1	1	57

Marie‐Hélène Delfau‐Larue

112

Publications

8.2K

Citations

H-Index

Page 1

	Year	Citations
Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network Olivier Hermine, Eva Hoster, Jan Walewski, The Lancet Hematological MalignancyLymphoid NeoplasiaOncologyTransplantationMantle Cell Lymphoma	2016	390
Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type Yen‐Lin Huang, Aurélien de Reyniès, Laurence de Leval, Blood	2009	307
Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936 Paul Evans, Ch Pott, Patricia J.T.A. Groenen, Leukemia B-cell MalignanciesLymphoid NeoplasiaHematological MalignancyMedicineImmunology	2006	296
Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study Christiane Pott, Eva Hoster, Marie‐Hélène Delfau‐Larue, Blood	2009	267
Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936 Monika Brüggemann, Harry N White, Philippe Gaulard, Leukemia Lymphoid NeoplasiaOncologyT-cell Malignancies ReportTumor HeterogeneityMedicine	2006	236
Expression of CXCL13 by Neoplastic Cells in Angioimmunoblastic T-Cell Lymphoma (AITL) Jehan Dupuis, K. Boye, Nadine Martin, The American Journal of Surgical Pathology Lymphoid NeoplasiaAutoimmune DiseaseMedicineMalignant Blood DisorderT-regulatory Cell	2006	228
Peripheral T-cell Lymphomas With a Follicular Growth Pattern are Derived From Follicular Helper T Cells (TFH) and may Show Overlapping Features With Angioimmunoblastic T-cell Lymphomas Yenlin Huang, Jehan Dupuis, Berthold Streubel, The American Journal of Surgical Pathology T-regulatory CellImmunologyFollicular Growth PatternPathologyDermatology	2009	210
CD5-CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas [see comments] Emile Jf, M-L Boulland, Corinne Haïoun, Blood	1996	201
Uncontrolled Innate and Impaired Adaptive Immune Responses in Patients with COVID-19 Acute Respiratory Distress Syndrome Sophie Hüe, Asma Beldi‐Ferchiou, Inès Bendib, American Journal of Respiratory and Critical Care Medicine	2020	199
Nonhepatosplenic gammadelta T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization. Bertrand Arnulf, Christiane Copie‐Bergman, Marie‐Hélène Delfau‐Larue, PubMed	1998	198

Page 1